Last update : 07/23/2015 | Version : 2 | ID : 5087
General | |
Identification | |
Detailed name | Digestive Cancers and Implantable Venous Catheter Infections |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | 908152 |
General Aspects | |
Medical area |
Gastroenterology et hepatology |
Health determinants |
Iatrogenic |
Keywords | central venous catheter, Assessment, impact, incidence, infection, mortality |
Scientific investigator(s) (Contact) | |
Name of the director | Chambrier |
Surname | Cécile |
Address | 104, Grande Rue de la Croisse Rousse, 69004 Lyon |
Phone | + 33 (0)4 72 00 15 25 |
cecile.chambrier@chu-lyon.fr | |
Unit | Unité CARMENInserm 1060/ Inra 1235 (Equipe 1) |
Organization | Hospices Civils de Lyon |
Collaborations | |
Funding | |
Funding status |
Mixed |
Details | Prix Société Francophone Nutrition Clinique et Métabolisme.Hospices Civils de LyonPrix Association Lyonnaise de Logistique Posthospitalière (A.L.L.P) |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Hospices Civils de Lyon (HCL) |
Organisation status |
Public |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Longitudinal study (except cohorts) |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Database objective | |
Main objective | The main objective is to assess the risk factors for central venous catheter–related infections and mortality in 30 days following onset of infection in patients with digestive cancer. The secondary objective is to assess the impact of sarcopenia on central venous catheter-related infections and mortality in 30 days following onset of infection in patients with digestive cancer. |
Inclusion criteria | Patients over the age of 18 with digestive cancer who have been monitored since March 2007. Patients diagnosed with primary digestive cancer who are receiving intravenous chemotherapy and have a central venous access port in place |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
Local |
French regions covered by the database |
Auvergne Rhône-Alpes |
Detail of the geography area | Lyon |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 03/2007 |
Size of the database | |
Size of the database (number of individuals) |
[500-1000[ individuals |
Details of the number of individuals | 525 |
Data | |
Database activity |
Current data collection |
Type of data collected |
Clinical data Declarative data Paraclinical data Biological data Administrative data |
Clinical data (detail) |
Medical registration |
Declarative data (detail) |
Face to face interview |
Paraclinical data (detail) | The presence of a stoma, cancer site, cancer stage, underlying pathologies, insertion site of central venous catheter (CVC), date CVC was put in place, intra-venous treatment, date and reasons for end of observation |
Biological data (detail) | Albumin levels, C-reactive protein (CRP) |
Administrative data (detail) | Date of birth |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity Health event/mortality Health care consumption and services |
Care consumption (detail) |
Hospitalization Medical/paramedical consultation Medicines consumption |
Procedures | |
Data collection method | Enrolment date corresponds to date central venous catheter was put in place. Each patient is monitored for a maximum period of 12 months. End of observation criteria are: central venous catheter infection, end of intra-venous chemotherapy, catheter ablation, transfer to another hospital, or death |
Participant monitoring |
Yes |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://tinyurl.com/Hal-Cancers-digestifs |
Description | List of publications in HAL |
Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/?term=Chambrier+C[author]+AND+cancer+AND+catheter |
Description | List of publications in Pubmed |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Publications Totally implantable central venous access port infections in patients with digestive cancer: Incidence and risk factors. Touré A, Vanhems P, Lombard-Bohas C, Cassier P, Péré-Vergé D, Souquet JC, Ecochard R, Chambrier C. Am J Infect Control. 2012 Dec;40(10):935-9. doi: 10.1016/j.ajic.2012.01.024. Epub 2012 May 26. PMID:22633131 Is diabetes a risk factor for central venous access port-related bloodstream infection in oncological patients? Touré A, Vanhems P, Lombard-Bohas C, Souquet JC, Lauverjat M, Chambrier C. Eur J Clin Microbiol Infect Dis. 2012 Aug 22. PMID:22930406 |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05